Ebola Outbreak Exposes Gaps as UN Prepares to Endorse 100 Days Mission

Global health leaders gathered on the sidelines of the UN General Assembly to take stock of the 100 Days Mission — the ambitious goal of having diagnostics, therapeutics, and vaccines ready within 100 days of a pandemic threat — just as a real-world Ebola outbreak was proving the target remains out of reach. With a political declaration expected to formally endorse the goal this week, panelists wrestled with a central tension: the world is faster than it was during COVID-19, but still not fast enough.

• UN political declaration expected to include the 100 Days Mission goal for the first time, creating a global accountability framework for rapid medical countermeasure development
• Bundibugyo Ebola outbreak surpasses 100 days without approved therapeutics or vaccines, even as record trial enrollment and manufacturing speed show major preparedness gains
• Six of 14 WHO priority viral families have zero therapeutic candidates in clinical development, exposing severe antiviral pipeline gaps
• Pharma industry warns PABS negotiations are actively slowing the Bundibugyo response and could deter future industry participation in pandemic preparedness
• Brazil unveils 100% domestic mRNA platform approved for Phase 1 trials and WHO-designated regional biomanufacturing center
• Diagnostics called the "neglected pillar" — no point-of-care test exists for Bundibugyo Ebola despite rapid molecular test deployment

Why it matters: The expected inclusion of the 100 Days Mission in the UN high-level meeting political declaration would mark the first time all member states formally endorse a rapid medical countermeasure timeline — shifting the goal from voluntary aspiration to declared global policy.